APA (7th ed.) Citation

Topal, A., Akdag, G., Yildirim, S., Kinikoglu, O., Isik, D., Yildirim, G., . . . Karadurmus, N. Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study. MDPI AG.

Chicago Style (17th ed.) Citation

Topal, Alper, et al. Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study. MDPI AG.

MLA (9th ed.) Citation

Topal, Alper, et al. Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study. MDPI AG.

Warning: These citations may not always be 100% accurate.